{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:58:32Z","timestamp":1791687512401,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014008","name":"Ovarian Cancer Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013401","name":"Ovarian Cancer Research Fund Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ygyno.2025.08.009","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T12:49:48Z","timestamp":1755866988000},"page":"118-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["\u201cWhat you're hearing from all of us is simplify the language\u201d: Patient perspectives on biomarker testing in ovarian cancer"],"prefix":"10.1016","volume":"201","author":[{"given":"Anna Jo","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"DeFeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2025.08.009_bb0005","doi-asserted-by":"crossref","first-page":"100.e1","DOI":"10.1016\/j.ajog.2022.08.043","article-title":"Disparities in biomarker testing in ovarian cancer: a real-world analysis","volume":"228","author":"Smith","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2025.08.009_bb0010","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian Cancer","volume":"381","author":"Gonz\u00e1lez-Mart\u00edn","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2025.08.009_bb0015","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance Olaparib in patients with newly diagnosed advanced ovarian Cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2025.08.009_bb0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ygyno.2017.06.002","article-title":"Multi-disciplinary summit on genetics services for women with gynecologic cancers: a Society of Gynecologic Oncology White Paper","volume":"146","author":"Randall","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2025.08.009_bb0025","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1200\/JCO.19.02960","article-title":"Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline","volume":"38","author":"Konstantinopoulos","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.08.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2023.107839","article-title":"Current communication practices for biomarker testing in non-small cell lung cancer: exploring patient and clinician perspectives","volume":"114","author":"Pack","year":"2023","journal-title":"Patient Educ. Couns."},{"issue":"1","key":"10.1016\/j.ygyno.2025.08.009_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13053-022-00238-w","article-title":"Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing","volume":"20","author":"Bokkers","year":"2022","journal-title":"Hered Cancer Clin Pract."},{"issue":"1","key":"10.1016\/j.ygyno.2025.08.009_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10897-017-0135-2","article-title":"Cancer genetic counseling and testing: perspectives of epithelial ovarian cancer patients and gynecologic oncology healthcare providers","volume":"27","author":"Liang","year":"2018","journal-title":"J. Genet. Couns."},{"issue":"4","key":"10.1016\/j.ygyno.2025.08.009_bb0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41431-018-0310-4","article-title":"Communication about genetic testing with breast and ovarian cancer patients: a scoping review","volume":"27","author":"Jacobs","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.ygyno.2025.08.009_bb0050","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/1049732303253488","article-title":"Classifying the findings in qualitative studies","volume":"13","author":"Sandelowski","year":"2003","journal-title":"Qual. Health Res."},{"issue":"1","key":"10.1016\/j.ygyno.2025.08.009_bb0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/13814788.2017.1375090","article-title":"Series: practical guidance to qualitative research. Part 2: context, research questions and designs","volume":"23","author":"Korstjens","year":"2017","journal-title":"Eur. J. Gen. Pract."},{"key":"10.1016\/j.ygyno.2025.08.009_bb0060","article-title":"Biomarker testing","volume":"9","author":"LUNGevity Foundation","year":"2024","journal-title":"LUNGevity Foundation"},{"key":"10.1016\/j.ygyno.2025.08.009_bb0065","author":"Precision Medicine Podcast"},{"key":"10.1016\/j.ygyno.2025.08.009_bb0070","series-title":"Navigating hope: how comprehensive biomarker testing is guiding lung cancer care","volume":"31","author":"LUNGevity Foundation","year":"2023"},{"key":"10.1016\/j.ygyno.2025.08.009_bb0075","series-title":"All about biomarker testing and KRAS+ lung cancer","volume":"6","author":"LUNGevity Foundation","year":"2022"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825009588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825009588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:37:34Z","timestamp":1772789854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825009588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":15,"alternative-id":["S0090825825009588"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.08.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cWhat you're hearing from all of us is simplify the language\u201d: Patient perspectives on biomarker testing in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}